Abstract
Diabetes is an established risk factor for erectile dysfunction (ED). The pathophysiology of ED in diabetic men is multifactorial, but it mainly involves a vascular disorder related to a reduction of endothelial function. Recently, several studies have correlated ED risk factors with vitamin D deficiency. In this study, we evaluate the relationship between 25-hydroxyvitamin D [25(OH)D] levels, erectile dysfunction, and vascular disease, in type 2 diabetes mellitus men (T2DM). In this observational study, 92 T2DM males (58.83 ± 9.73 years) underwent medical history collection, International Index of Erectile Function (IIEF-5) questionnaire, that allows the identification and grading of DE, physical examination, biochemical/hormonal blood tests, and penile echo-color Doppler ultrasonography. T2DM patients with lower 25(OH)D levels (<25 nmol/l) showed higher penile IMT (p < 0.05), waist circonference (p < 0.05), glucose concentrations (p < 0.05), and lower IIEF-5 score (p < 0.005), testosterone concentrations (p < 0.05), and cavernous peak systolic velocity (PSV) (p < 0.05), compared to patients with 25(OH)D >50 nmol/l. 25(OH)D levels were directly correlated with IIEF-5 (R = 0.39; p = 0.0001), testosterone (R = 0.24; p = 0.02), and PSV (R = 0.24; p = 0.04) and inversely with waist (R = −0.33; p = 0.002), HbA1c (R = −0.22; p = 0.03), triglyceride (R = −0.21; p = 0.06), and penile IMT (R = −0.30; p = 0.009). At multivariate analysis, 25(OH)D deficiency remained an independent predictor of DE. We demonstrate a significant association between 25(OH)D deficiency and erectile dysfunction in T2DM men. This association may be due to the influence of 25(OH)D deficiency on cardiovascular risk factor (glycaemia, HDL cholesterol, and triglycerides), testosterone plasma levels and endothelial dysfunction.
Similar content being viewed by others
References
E. Selvi, A.L. Burnett, E.A. Platz, Prevalence and risk factors fer erectile dysfunction in the US. Am. J. Med. 120, 151–157 (2007)
L.S. Malavige, J.C. Levy, Erectile dysfunction in diabetes mellitus. J Sex Med 6, 1232–1247 (2009)
H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, J.B. McKinlay, Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol. 151, 54–61 (1994)
C. Gazzaruso, A. Coppola, T. Montalcini et al., Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes. Endocrine 40, 273–279 (2011)
M.E. Sullivan, C.S. Thompson, M.R. Dashwood et al., Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res. 43, 658–665 (1999)
K.L. Billups, A.J. Bank, H. Padma-Nathan, S.D. Katz, R.A. Williams, Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int. J. Impot. Res. 20, 236–242 (2008)
H. Solomon, J.W. Man, G. Jackson, Erectile dysfunction and the cardiovascular patient: endothelial dysfuntion is the common denominator. Heart 89, 251–253 (2003)
I.M. Bird, Endothelial nitric oxide synthase activation and nitric oxide funtion: new light throught old windows. J. Endocrinol. 210, 239–241 (2011)
L. Ghiadoni, S. Taddei, A. Virdis, Hypertension and endothelial dysfunction: therapeutic approach. Curr. Vasc. Pharmacol. 10, 42–60 (2012)
C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, C. Stefanadis, Inflammation, metabolic syndrom, erectile dysfunction, and coronary artery disease: common links. Eur. Urol. 52(6), 1590–1600 (2007)
C. Foresta, P.F. Palego, M. Schipilliti et al., Asymmetric development of pheriferal atherosclerosis in patients with erectile dysfunction: an ultrasonographic study. Atherosclerosis 197, 889–895 (2008)
J.P. Reis, D. von Muhlen, E.D. Michos et al., Serum vitamin D, parathyroid hormone levels and carotid atherosclerosis. Atherosclerosis 207, 585–590 (2009)
A.C. Borges, T. Feres, L.M. Vianna, T.B. Paiva, Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension 34, 897–901 (1999)
S. Vigili de Kreutzenberg, A. Coracina, A. Volpi et al., Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. NMCD 21, 286–293 (2011)
L. Polidoro, G. Properzi, F. Marampon et al., Vitamin D protects human endothelial cells from H(2)O(2) oxidant injury through the Mek/Erk-Sirt1 axis activation. J. Cardiovasc. Transl. Res. 6, 221–231 (2013)
A. Barassi, R. Pezzilli, G.M. Colpi, M.M. Corsi Romanelli, G.V. Melzi d’Eril, Vitamin D and erectile dysfunction. J. Sex Med. 11, 2792–2800 (2014)
W.B. Grant, M. Sorenson, B.J. Boucher, Vitamin D deficiency may contribute to the explanation of the link between chronic periodontitis and edectile dysfunction. J. Sex Med. 10, 2353–2354 (2013)
M. Sorenson, W.B. Grant, Does vitamin D deficiency contribute to erectile dysfunction? Dermatoendocrinology 4, 128–136 (2012)
Y. Song, L. Wang, A.G. Pittas et al., Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care 36(5), 1422–1428 (2013)
D.J. Al-Tamini, A.F. Ali, Serum 25(OH) D in diabetes mellitus type 2: relation to glycaemic control. J. Clin. Diagn. Res. 7, 2686–2688 (2013)
B.J. Boucher, W.G. John, K. Noonan, Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 80, 1666–1667 (2004)
V. Hirani, Relationship between vitamin D and hyperglycemia in older people from a nationally representative population survey. J. Am. Geriatr. Soc. 59, 1786–1792 (2011)
R. Scragg, M. Sowers, C. Bell, Serum 25-hydroxyvitamin D, diabetes and ethnicity in the third national health and nutrition examination survey. Diabetes Care 27, 2813–2818 (2004)
C. Foresta, N. Caretta, G. Corona et al., Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart. Int. J. Androl. 32, 198–211 (2009)
N. Caretta, P. Palego, Schipilliti et al., Cavernous artery intima media thickness: a new parameter in the diagnosis of vascular erectile dysfunction. J. Sex Med. 6, 1117–1126 (2009)
F.A. Giuliano, A. Leriche, E.O. Jaudinot, A.S. de Gendre, Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 64, 1196–1201 (2004)
D. Liu, B.O. Fernandez, A. Hamilton et al., UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase. J. Invest. Dermatol. 134, 1839–1846 (2014)
C. Oplander, C.M. Volkmar, A. Paune-Gorgulu et al., Whole body UVA irradiation lowers systemic blood pressure by releae of nitric oxide from intracutaneous photolabile nitric oxide derivates. Circ. Res. 105, 1031–1040 (2009)
G. Corona, G. Rastrelli, S. Filippi et al., Erectile dysfunction and central obesity: an Italian perspective. Asian J. Androl. 16, 581–591 (2014)
A.T. Drincic, L.A. Armas, E.E. Van Diest, R.P. Heaney, Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 20(7), 1444–1448 (2012)
E. Wehr, S. Pilz, B.O. Boehm, W. Marz, B. Obermayer-Pietsch, Association of vitamin D status with serum androgen levels in men. Clin. Endocrinol. 73, 243–248 (2010)
S. Pilz, S. Frisch, H. Koertke et al., Effect of vitamin D supplementation on testosterone levels in men. Horm. Metab. Res. 43(3), 223–225 (2011)
J.M. Blomberg, J.E. Nielsen, A. Jorgensen et al., Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum. Reprod. 25, 1303–1311 (2010)
D.W. Eyles, S. Smith, R. Kinobe, M. Hewison, J.J. McGrath, Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 29, 21–30 (2005)
R. Perez-Fernandez, M. Alonso, C. Segura et al., Vitamin D receptor gene expression in human pituitary gland. Life Sci. 60, 35–42 (1997)
L.S.F. Carvalho, A.C. Sposito, Vitamin D for the prevention of cardiovascular disease: are we ready for that? Atherosclerosis 241, 729–740 (2015)
M.I. Ullah, G.I. Uwaifo, W.C. Nicholas, C.A. Koch, Does vitamin D deficiency cause hypertension? Current evidence from clinical studies and potential mechanisms. Int. J. Endocrinol. 2010, 579–640 (2010)
O. Andrukhova, S. Slavic, U. Zeitz et al., Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol. Endocrinol. 28, 53–64 (2014)
M.S. Wong, R. Delansorne, R.Y. Man, P. Svenningsen, P.M. Vanhoutte, Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol. 299, 1226–1234 (2010)
M. Hirata, K. Serizawa, K. Aizawa et al., 22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy. Nephrol. Dial. Transpl. 28, 1166–1174 (2013)
J.J. Cannell, W.B. Grant, M.F. Holick, Vitamin D and inflammation. Dermatoendocrinology 6(1), e983401 (2015)
Y. Talmor, J. Bernheim, O. Klein, J. Green, G. Rashid, Calcitriol blunts proatherosclerotic parameters through NFkappaB and p38 in vitro. Eur. J. Clin. Invest. 38, 548–554 (2008)
K. Kudo, S. Hasegawa, Y. Suzuki et al., 1alpha,25-dihydroxyvitamin D(3) inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial endothelial cells. J. Steroid Biochem. Mol. Biol. 132, 290–294 (2012)
M.P. Ponda, X. Huang, M.A. Odeh, J.L. Breslow, H.W. Kaufman, Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 126, 270–277 (2012)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Caretta, N., de Kreutzenberg, S.V., Valente, U. et al. Hypovitaminosis D is associated with erectile dysfunction in type 2 diabetes. Endocrine 53, 831–838 (2016). https://doi.org/10.1007/s12020-015-0851-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-015-0851-z